USANA First Quarter Net Sales Rise 15.5 Percent to 308 Million

USANA Health Sciences reported first-quarter net sales of 308.0 million dollars for the fiscal period ended April 3, 2021, up 15.5 percent from a year earlier. Diluted earnings rose 17.9 percent to 1.45 dollars a share. Active customers rose 7.7 percent to 617,000.

Chief executive Kevin Guest said demand for the company products stayed strong and that each region posted double-digit sales growth. Asia Pacific was 81.6 percent of sales at 251.3 million dollars. Americas and Europe sales rose 11.1 percent to 56.7 million dollars. The company ended the quarter with 257 million dollars in cash and no debt, and it bought back 721,000 shares for 69.5 million dollars.

Guest said the Active Nutrition line launched in late March in the United States, Canada, Mexico, Australia, and New Zealand, with more markets planned later in the year. Full-year guidance was raised to net sales of 1.24 billion to 1.28 billion dollars and diluted earnings of 6.15 to 6.50 dollars a share.